Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	283,575	181,305	297,962	170,528	81,683	-
Market Cap Growth	11.35%	-39.15%	74.73%	108.77%	-	-
Enterprise Value	327,141	222,374	341,742	209,922	130,128	-
Last Close Price	213.67	136.54	224.60	128.72	66.76	-

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	-	-	326.96	956.95	-	-
Forward PE	93.71	82.54	70.54	42.33	40.39	-
PS Ratio	3.08	2.04	3.26	2.09	1.15	-
PB Ratio	3.47	2.22	3.67	2.15	1.21	-
P/TBV Ratio	7.05	4.51	7.38	4.71	3.51	-
P/FCF Ratio	37.19	23.78	130.73	58.30	-	-
P/OCF Ratio	17.16	10.97	33.39	16.98	16.88	-
PEG Ratio	-	0.74	0.44	1.58	1.35	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	3.55	2.51	3.73	2.57	1.84	-
EV/EBITDA Ratio	32.62	26.62	24.92	18.43	22.58	-
EV/EBIT Ratio	151.38	232.39	54.01	45.62	-	-
EV/FCF Ratio	42.90	29.16	149.94	71.77	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.70	0.70	0.60	0.60	0.83	0.62
Debt / EBITDA Ratio	6.05	6.47	3.44	4.00	9.21	3.63
Debt / FCF Ratio	-	7.49	21.31	16.10	-	-
Net Debt / Equity Ratio	0.53	0.53	0.55	0.53	0.74	0.57
Net Debt / EBITDA Ratio	4.85	5.22	3.24	3.68	8.70	3.47
Net Debt / FCF Ratio	-	5.71	19.52	14.34	-10.43	-31.27
Asset Turnover	-	0.53	0.59	0.55	0.52	0.57
Inventory Turnover	-	1.33	1.58	1.69	1.94	1.87
Quick Ratio	-	0.76	0.75	0.61	0.64	0.69
Current Ratio	-	1.51	1.54	1.25	1.26	1.34
Return on Equity (ROE)	-	-4.00%	1.14%	0.24%	-2.77%	6.11%
Return on Assets (ROA)	-	0.36%	2.55%	1.93%	-0.20%	2.96%
Return on Invested Capital (ROIC)	1.26%	0.76%	1.13%	0.38%	-0.40%	4.62%
Return on Capital Employed (ROCE)	-	0.70%	5.30%	4.20%	-0.40%	5.70%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	-1.11%	-1.80%	0.31%	0.10%	-2.28%	-
FCF Yield	2.69%	4.21%	0.77%	1.71%	-5.89%	-
Dividend Yield	0.07%	-	0.06%	0.08%	-	-
Payout Ratio	-	-	15.88%	-	-	13.30%
Buyback Yield / Dilution	-0.01%	0.40%	-3.67%	-7.85%	-0.95%	-87.83%
Total Shareholder Return	0.05%	0.40%	-3.61%	-7.76%	-0.95%	-87.83%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error